Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Ariel Kantor

DPhil Student and Rhodes Scholar

Ariel is the recipient of the prestigious Rhodes Scholarship. Before moving to Oxford, Ariel completed his undergraduate studies in Bioengineering at Duke University, graduating summa cum laude with top distinction. There, he conducted research focused on the development of CRISPR epigenetic-editing technologies in the laboratory of Professor Charles Gersbach.

Ariel is currently working towards a DPhil in Clinical Neurosciences under the supervision of Professor Robert MacLaren. His research focuses on the application of CRISPR-Cas9 as a novel technique in the treatment of inherited macular degenerations, including retinitis pigmentosa. 

Recent publications

More publications